SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies
…, N Di Lauria, L Salvati, A Carnasciali… - The Journal of …, 2022 - Am Soc Clin Investig
BACKGROUND Immunization against SARS-CoV-2, the causative agent of COVID-19, occurs
via natural infection or vaccination. However, it is currently unknown how long infection- or …
via natural infection or vaccination. However, it is currently unknown how long infection- or …
SARS-CoV-2 spike-specific CD4+ T cell response is conserved against variants of concern, including omicron
Although accumulating data have investigated the effect of SARS-CoV-2 mutations on antibody
neutralizing activity, less is known about T cell immunity. In this work, we found that the …
neutralizing activity, less is known about T cell immunity. In this work, we found that the …
Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalization
…, B Peruzzi, S Bencini, M Capone, A Carnasciali… - Journal of Clinical …, 2022 - Springer
Background and Purpose Waning immunity and the surge of SARS-CoV-2 variants are
responsible for breakthrough infections, ie, infections in fully vaccinated individuals. Although the …
responsible for breakthrough infections, ie, infections in fully vaccinated individuals. Although the …
Graphene oxide nanosheets reduce astrocyte reactivity to inflammation and ameliorate experimental autoimmune encephalomyelitis
In neuroinflammation, astrocytes play multifaceted roles that regulate the neuronal environment.
Astrocytes sense and respond to pro-inflammatory cytokines (CKs) and, by a repertoire …
Astrocytes sense and respond to pro-inflammatory cytokines (CKs) and, by a repertoire …
TCR repertoire diversity in Multiple Sclerosis: High-dimensional bioinformatics analysis of sequences from brain, cerebrospinal fluid and peripheral blood
…, M Chernigovskaya, V Greiff, A Carnasciali… - …, 2021 - thelancet.com
Background T cells play a key role in the pathogenesis of multiple sclerosis (MS), a chronic,
inflammatory, demyelinating disease of the central nervous system (CNS). Although several …
inflammatory, demyelinating disease of the central nervous system (CNS). Although several …
The TCR repertoire reconstitution in multiple sclerosis: comparing one-shot and continuous immunosuppressive therapies
…, V Greiff, A Aldinucci, E Bonechi, A Carnasciali… - Frontiers in …, 2020 - frontiersin.org
Natalizumab (NTZ) and autologous hematopoietic stem cell transplantation (AHSCT) are two
successful treatments for relapsing-remitting multiple sclerosis (RRMS), an autoimmune T-…
successful treatments for relapsing-remitting multiple sclerosis (RRMS), an autoimmune T-…
Clonally expanded PD‐1‐expressing T cells are enriched in synovial fluid of juvenile idiopathic arthritis patients
…, G Lamacchia, L Salvati, A Carnasciali… - European journal of …, 2023 - Wiley Online Library
Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic condition in childhood.
The disease etiology remains largely unknown; however, a key role in JIA pathogenesis …
The disease etiology remains largely unknown; however, a key role in JIA pathogenesis …
Fourth dose of mRNA COVID-19 vaccine transiently reactivates spike-specific immunological memory in people living with HIV (PLWH)
Background: People Living With HIV (PLWH), with advanced disease, lower CD4+ T cell
counts or an unsuppressed HIV viral load can have a suboptimal vaccine response. For this …
counts or an unsuppressed HIV viral load can have a suboptimal vaccine response. For this …
T cell delivery of nanoparticles-bound anti-CD20 monoclonal antibody: successful B cell depletion in the spinal cord during experimental autoimmune …
A Carnasciali, R Amoriello, E Bonechi… - Journal of Neuroimmune …, 2021 - Springer
We developed a nanotechnology based-cell mediated drug delivery system by loading myelin
antigen-specific T cells with nanoparticles bound to anti-CD20 monoclonal antibody. Anti-…
antigen-specific T cells with nanoparticles bound to anti-CD20 monoclonal antibody. Anti-…
Long-lasting cellular immunity to SARS-CoV-2 following infection or vaccination and implications for booster strategies
…, M Capone, N Di Lauria, L Salvati, A Carnasciali… - medRxiv, 2021 - medrxiv.org
Immunization against SARS-CoV-2, the causative agent of coronavirus disease-19 (COVID-19)
occurs via natural infection or vaccination. However, it is currently unknown how long …
occurs via natural infection or vaccination. However, it is currently unknown how long …
